What is the current soft capsules drugs cmo market size?

The soft capsules drugs cmo market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the soft capsules drugs cmo market?

Increasing demand for soft capsules and advancements in technology are key drivers.

What are the major challenges faced by the market?

Stringent regulations and high production costs are major challenges.

Which regions are leading the soft capsules drugs cmo market?

North America and Europe are leading the market due to high demand.

Who are the top companies in the soft capsules drugs cmo market?

Top companies include Catalent and Lonza, which offer high-quality services.

What are the future opportunities in the soft capsules drugs cmo market?

Emerging markets and increasing demand for soft capsules offer future opportunities.

How is technology impacting the soft capsules drugs cmo market?

Advances in technology are improving production efficiency and quality.

What is the current regulatory landscape for the market?

The market is regulated by authorities such as FDA and EMA.

What is the future outlook for the soft capsules drugs cmo market?

The market is expected to grow due to increasing demand and advancements.

What Is the Global soft capsules drugs cmo Market Worth in 2026?

soft capsules drugs cmo by Application (Health Supplements, Pharmaceutical, Others), by Types (Gelatin Type, Non-animal Type) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

soft capsules drugs cmo Market Overview

The soft capsules drugs CMO market refers to the outsourcing of soft capsules drug manufacturing to contract manufacturing organizations (CMOs). As the soft capsules drugs CMO market size is expected to reach $8.5 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry. The industry expansion is driven by the increasing demand for soft capsules drugs, particularly in the pharmaceutical and nutraceutical sectors, with a focus on contract manufacturing and outsourcing trends. The scope of the market includes soft capsules, drug manufacturing, and contract manufacturing organizations.

Loading chart…

The current soft capsules drugs CMO market size is estimated to be around $6.5 billion, with a growth forecast indicating a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. The market is driven by macro drivers such as the increasing demand for soft capsules drugs, advancements in technology, and changing regulations. Key forces shaping the industry include technology shifts towards more efficient manufacturing processes, regulations governing the outsourcing of drug manufacturing, and competitive intensity among CMOs. The largest region for the soft capsules drugs CMO market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for soft capsules drugs in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	23.19 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Catalent; Aenova; Nature's Bounty; Procaps; Patheon (Thermo Fisher Scientific); IVC; EuroCaps; Captek; Strides Pharma Science; Lonza (Capsugel); Soft Gel Technologies; Sirio Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The soft capsules drugs cmo market is experiencing significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the soft capsules drugs cmo market size and growth forecast.

Growth Drivers2 items

Increasing demand for oral medications and the growing preference for soft capsules as a dosage form due to their ease of swallowing and improved bioavailability

Advancements in encapsulation technology and the development of new excipients that enhance the stability and efficacy of soft capsules

Restraints2 items

High production costs associated with soft capsules, particularly for complex formulations that require specialized equipment and expertise

Stringent regulatory requirements and quality standards that must be met by contract manufacturers to ensure the safety and efficacy of soft capsules

Opportunities2 items

Growing demand for soft capsules in emerging markets where there is a need for affordable and accessible medications, presenting opportunities for soft capsules drugs cmo market players to expand their presence

Increasing focus on sustainability and environmental responsibility in the pharmaceutical industry, driving the development of eco-friendly soft capsules and packaging solutions

Challenges2 items

Intense competition in the soft capsules drugs cmo market, with many players vying for market share and pricing pressure that can erode profit margins

Managing supply chain risks and ensuring the quality and reliability of raw materials and components used in soft capsule production

Market Segmentation

Loading chart…

The soft capsules drugs cmo market can be segmented based on application, which includes various therapeutic areas such as infectious diseases, oncology, and cardiovascular diseases. This soft capsules drugs cmo segmentation is crucial in understanding the market size and growth prospects. Each application segment contributes to the overall market size, with some segments expected to grow faster than others due to increasing demand for soft capsule formulations.

In terms of types, the soft capsules drugs cmo market can be categorized into gelatin-based and non-gelatin-based soft capsules, containing subtypes such as hard gelatin capsules and soft gelatin capsules. Understanding these subtypes is essential for market taxonomy, as they have different manufacturing processes, costs, and applications. The gelatin-based soft capsules segment is expected to dominate the market due to its widespread use and well-established manufacturing process.

soft capsules drugs cmo Segmentation Breakdown7 items

Application

Health Supplements

Pharmaceutical

Others

Types

Gelatin Type

Non-animal Type

Regional Insights

Loading chart…

The soft capsules drugs cmo market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of soft capsules, favorable policies, and significant investments in the pharmaceutical industry.

Key drivers for each region include: North America, driven by a mature ecosystem, high demographics demand, and established infrastructure; Europe, influenced by stringent policies, a strong pharmaceutical industry, and growing adoption of soft capsules; Asia Pacific, fueled by rapid investments, increasing demographics, and expanding infrastructure; Latin America, impacted by growing adoption, improving infrastructure, and rising demographics; and Middle East & Africa, driven by increasing investments, growing demographics, and improving ecosystem maturity.

The regional forecast indicates a significant opportunity for growth in the soft capsules drugs cmo market, with the Asia Pacific region expected to drive the market forward. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The soft capsules drugs cmo market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The soft capsules drugs cmo competitive landscape is characterized by high competition, with companies focusing on differentiation through quality, reliability, and customer service. Pricing is a critical factor, with companies seeking to balance profitability with affordability.

Companies in the soft capsules drugs cmo market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted specific strategic focuses:

Catalent: regional expansion

Aenova: vertical integration

Nature's Bounty: premium pricing

Procaps: OEM tie-ups

Patheon (Thermo Fisher Scientific): innovation pipeline

Lonza (Capsugel): local manufacturing

Key soft capsules drugs cmo Companies12 items

Catalent

Aenova

Nature's Bounty

Procaps

Patheon (Thermo Fisher Scientific)

IVC

EuroCaps

Captek

Strides Pharma Science

Lonza (Capsugel)

Soft Gel Technologies

Sirio Pharma

Market Ecosystem

The soft capsules drugs cmo ecosystem spans the entire value chain, from upstream technology providers and raw material suppliers to midstream integrators and manufacturers, and downstream to channels and end users. This ecosystem is characterized by a complex interplay of participants, each contributing to the creation and capture of value. Understanding the boundaries and dynamics of this ecosystem is crucial for navigating the soft capsules drugs cmo market, particularly in the context of a comprehensive value chain analysis.

Raw material suppliers — provide pharmaceutical ingredients

Technology providers — develop formulation and manufacturing technologies

OEMs / manufacturers — produce soft capsule drugs

System integrators / EPCs — integrate manufacturing systems

Distributors / channel partners — distribute finished products

Regulators/standards bodies — set quality and safety standards

End users / buyers — purchase and administer soft capsule drugs

The flow of value through the soft capsules drugs cmo ecosystem is influenced by various control points, such as regulatory approvals and quality standards. Dependency risks, including input constraints and standards compliance, can impact the availability and cost of raw materials and manufactured products. Switching costs and partnerships can also affect the flexibility of manufacturers and distributors to respond to changes in demand or supply. Furthermore, the ecosystem's dynamics can differ by region, reflecting variations in regulatory frameworks, market preferences, and the presence of local manufacturers and distributors.

Recent Industry Insights

The soft capsules drugs cmo market has witnessed significant developments over the last 12-18 months, shaping the soft capsules drugs cmo industry trends. Recent partnerships between contract manufacturers and pharmaceutical companies have led to increased outsourcing of soft capsule manufacturing. Notable mergers and acquisitions have also taken place, with major players expanding their capabilities and geographical reach. Furthermore, several product and technology launches have enhanced the efficiency and quality of soft capsule production.

Additionally, regulatory changes have prompted companies to adapt their manufacturing processes, ensuring compliance with updated standards. A shift in consumer preferences towards sustainable and environmentally-friendly packaging has also influenced the soft capsules drugs cmo industry trends. Funding rounds and expansions have enabled companies to invest in new technologies and increase their production capacities, driving growth in the market.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the soft capsules drugs cmo market presents a highly attractive opportunity for growth, driven by increasing demand for soft capsule formulations. The competitive intensity in this market is moderate, with key players focusing on innovation and expansion of their manufacturing capabilities. Looking at the soft capsules drugs cmo market outlook, I anticipate a long-term growth trajectory, underpinned by ongoing advancements in innovation landscape and rising demand for soft capsules. However, the market is not without risks, including fluctuations in demand-supply balance and regulatory challenges.

Key Insights3 items

The market is expected to experience a surge in demand, driven by the growing popularity of soft capsule formulations

Innovation in manufacturing technologies and processes will be crucial for companies to stay competitive

Key risk factors include regulatory changes, supply chain disruptions, and fluctuations in raw material prices

11 items

1. Executive Summary

2. soft capsules drugs cmo Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global soft capsules drugs cmo Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global soft capsules drugs cmo Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Health Supplements

6.1.2. Pharmaceutical

6.1.3. Others

6.2. Global soft capsules drugs cmo Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Gelatin Type

6.2.2. Non-animal Type

6.3. Global soft capsules drugs cmo Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global soft capsules drugs cmo Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global soft capsules drugs cmo Market by: Regions (Value)

8. Global soft capsules drugs cmo Market Competition by Key Manufacturers

8.1. Global soft capsules drugs cmo Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global soft capsules drugs cmo: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Catalent

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Aenova

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Nature's Bounty

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Procaps

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Patheon (Thermo Fisher Scientific)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. IVC

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. EuroCaps

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Captek

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Strides Pharma Science

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Lonza (Capsugel)

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Soft Gel Technologies

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Sirio Pharma

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global soft capsules drugs cmo Market

Figure 4: Global soft capsules drugs cmo Market: Drivers

Figure 5: Global soft capsules drugs cmo Market: Challenges

Figure 6: Global soft capsules drugs cmo Market: Trends

Figure 7: Global soft capsules drugs cmo Market: Opportunity

Figure 8: Global soft capsules drugs cmo Market: Restraint

Figure 9: Global soft capsules drugs cmo Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global soft capsules drugs cmo Market Value (USD Million) By Region

Figure 15: Global soft capsules drugs cmo Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global soft capsules drugs cmo Market Value (USD Million) By Region

Figure 23: Global soft capsules drugs cmo Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global soft capsules drugs cmo Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global soft capsules drugs cmo Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global soft capsules drugs cmo Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global soft capsules drugs cmo Market Value (USD Million) By Region

Table 10: Global soft capsules drugs cmo Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global soft capsules drugs cmo Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global soft capsules drugs cmo Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global soft capsules drugs cmo Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Catalent Basic Information And Sales Area

Table 31: Catalent. Products Portfolio

Table 32: Aenova Basic Information And Sales Area

Table 33: Aenova. Products Portfolio

Table 34: Nature's Bounty Basic Information And Sales Area

Table 35: Nature's Bounty. Products Portfolio

Table 36: Procaps Basic Information And Sales Area

Table 37: Procaps. Products Portfolio

Table 38: Patheon (Thermo Fisher Scientific) Basic Information And Sales Area

Table 39: Patheon (Thermo Fisher Scientific). Products Portfolio

Table 40: IVC Basic Information And Sales Area

Table 41: IVC. Products Portfolio

Table 42: EuroCaps Basic Information And Sales Area

Table 43: EuroCaps. Products Portfolio

Table 44: Captek Basic Information And Sales Area

Table 45: Captek. Products Portfolio

Table 46: Strides Pharma Science Basic Information And Sales Area

Table 47: Strides Pharma Science. Products Portfolio

Table 48: Lonza (Capsugel) Basic Information And Sales Area

Table 49: Lonza (Capsugel). Products Portfolio

Table 50: Soft Gel Technologies Basic Information And Sales Area

Table 51: Soft Gel Technologies. Products Portfolio

Table 52: Sirio Pharma Basic Information And Sales Area

Table 53: Sirio Pharma. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global soft capsules drugs cmo Market Value (USD Million) By Region

Table 59: Global soft capsules drugs cmo Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

soft capsules drugs cmo Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	23.19 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Catalent; Aenova; Nature's Bounty; Procaps; Patheon (Thermo Fisher Scientific); IVC; EuroCaps; Captek; Strides Pharma Science; Lonza (Capsugel); Soft Gel Technologies; Sirio Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for oral medications and the growing preference for soft capsules as a dosage form due to their ease of swallowing and improved bioavailability

Advancements in encapsulation technology and the development of new excipients that enhance the stability and efficacy of soft capsules

Restraints2 items

High production costs associated with soft capsules, particularly for complex formulations that require specialized equipment and expertise

Stringent regulatory requirements and quality standards that must be met by contract manufacturers to ensure the safety and efficacy of soft capsules

Opportunities2 items

Increasing focus on sustainability and environmental responsibility in the pharmaceutical industry, driving the development of eco-friendly soft capsules and packaging solutions

Challenges2 items

Intense competition in the soft capsules drugs cmo market, with many players vying for market share and pricing pressure that can erode profit margins

Managing supply chain risks and ensuring the quality and reliability of raw materials and components used in soft capsule production

Market Segmentation

Loading chart…

soft capsules drugs cmo Segmentation Breakdown7 items

Application

Health Supplements

Pharmaceutical

Others

Types

Gelatin Type

Non-animal Type

Regional Insights

Loading chart…

Competitive Landscape

Catalent: regional expansion

Aenova: vertical integration

Nature's Bounty: premium pricing

Procaps: OEM tie-ups

Patheon (Thermo Fisher Scientific): innovation pipeline

Lonza (Capsugel): local manufacturing

Key soft capsules drugs cmo Companies12 items

Catalent

Aenova

Nature's Bounty

Procaps

Patheon (Thermo Fisher Scientific)

IVC

EuroCaps

Captek

Strides Pharma Science

Lonza (Capsugel)

Soft Gel Technologies

Sirio Pharma

Market Ecosystem

Raw material suppliers — provide pharmaceutical ingredients

Technology providers — develop formulation and manufacturing technologies

OEMs / manufacturers — produce soft capsule drugs

System integrators / EPCs — integrate manufacturing systems

Distributors / channel partners — distribute finished products

Regulators/standards bodies — set quality and safety standards

End users / buyers — purchase and administer soft capsule drugs

Recent Industry Insights

Analyst Overview

Key Insights3 items

The market is expected to experience a surge in demand, driven by the growing popularity of soft capsule formulations

Innovation in manufacturing technologies and processes will be crucial for companies to stay competitive

Key risk factors include regulatory changes, supply chain disruptions, and fluctuations in raw material prices

Table of Contents